Biogen Inc. (BIIB.MX)
Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
At close: 09:47AM CST
| Previous close | 3,900.00 |
| Open | 0.00 |
| Bid | 0.00 x 100 |
| Ask | 0.00 x 100 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 7 |
| Market cap | 566.385B |
| Beta (5Y monthly) | 0.10 |
| PE ratio (TTM) | 22.57 |
| EPS (TTM) | 172.77 |
| Earnings date | 13 Feb 2024 - 19 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.The past five years for Biogen (NASDAQ:BIIB) investors has not been profitable
For many, the main point of investing is to generate higher returns than the overall market. But every investor is...
- Simply Wall St.
Here's Why Biogen (NASDAQ:BIIB) Can Manage Its Debt Responsibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Motley FoolThe Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?
It's a no-brainer to invest in businesses that are making headway in the growth markets of the future. In biopharma, therapies to treat or prevent Alzheimer's disease constitute one such growth market. Let's survey the competitive landscape as it is today, and think through how it's likely to develop.
© 2023 Yahoo. All rights reserved.